The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.
p21 in cancer: intricate networks and multiple activities
Open accessAbstract
One of the main engines that drives cellular transformation is the loss of proper control of the mammalian cell cycle. The cyclin-dependent kinase inhibitor p21 (also known as p21WAF1/Cip1) promotes cell cycle arrest in response to many stimuli. It is well positioned to function as both a sensor and an effector of multiple anti-proliferative signals. This Review focuses on recent advances in our understanding of the regulation of p21 and its biological functions with emphasis on its p53-independent tumour suppressor activities and paradoxical tumour-promoting activities, and their implications in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“p21 is a potent cell-cycle inhibitor (39)”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [39]
In the citing paper
“CDKN1A (p21, WAF1, CIP1) was among the first p53 target genes11, 12 to be identified and is now recognized as an encoder for a major cell cycle checkpoint control protein.145”
From Census and evaluation of p53 target genes (2017) · cites this paper as [145]
In the citing paper
“As p21 is rarely genetically affected in cancers [1,124]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [1]
In the citing paper
“Members of the Krüppel-like factor (KLF) transcription factor (TF) family can activate the CDKN1A gene by cooperating with p300-CREBBP (Aliouat-Denis et al., 2005; Abbas and Dutta, 2009).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“p21WAF1/CIP1 can also be activated by p53 independent mechanisms by other stimulators such as nuclear receptors including androgen, vitamin D and retinoid receptors.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“Although this is the first detectable event, it is more likely that main role of p21 lies in its capacity to trigger pRb-mediated repression of cell cycle regulators (Fig. 2, for more information on p21 functions (see ref. 98 ).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [98]
In the citing paper
“For example, cyclin-dependent kinase inhibitor 1A (CDKN1A), a tumor suppressor that is downregulated in multiple cancers (106), is targeted by at least 28 miRNAs and many of which are upregulated together in cancers where CDKN1A has been implicated (107).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK1, at least in some tissues, may be the crucial target of p21 in tumorigenesi”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Xu, X., Yuan, G., Li, Q., Shan, S.-L., & Jiang, S. (2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Recent work suggests that tumour regression can be achieved through the reactivation of senescence, for example by restoring p53 functio”
BackgroundPCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Flagged first, then by citations
2 of the 236 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Martin-Caballero, J., Flores, J. M., Garcia-Palencia, P. & Serrano, M. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 61, 6234–6238 (2001). This study demonstrates that deletion of Cdkn1a in mice results in spontaneous tumours but with late onset.
Cited by
Sorted by citations
Items 201–300 of 1,005
Li, X. L., Hara, T., Choi, Y., Subramanian, M., Francis, P., Bilke, S., Walker, R. L., Pineda, M. A., Zhu, Y. J., Yang, Y.-A., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01043-13 · Cited by 103
Dai, M., Al-Odaini, A. A., Fils-Aimé, N., Villatoro, M., Guo, J., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2013) · Breast Cancer Research · doi:10.1186/bcr3441 · Cited by 103
A map of protein dynamics during cell-cycle progression and cell-cycle exit
Gookin, S. E., Min, M., Phadke, H., Chung, M., Moser, J. C., Miller, I., Carter, D., & Spencer, S. L. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003268 · Cited by 103
Royston, K. J., Paul, B., Nozell, S. E., Rajbhandari, R., & Tollefsbol, T. O. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.015 · Cited by 101
Park, Y.-H., Kim, D., Dai, J., & Zhang, Z. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.008 · Cited by 104
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
Bacco, F. D., D'Ambrosio, A., Casanova, E., Orzan, F., Neggia, R., Albano, R., Verginelli, F., Cominelli, M., Poliani, P. L., Luraghi, P., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505890 · Cited by 105
The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells
Hütz, K., Mejías‐Luque, R., Farsakova, K., Ogris, M., Krebs, S., Anton, M., Vieth, M. W., Schüller, U., Schneider, M. R., Blum, H., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt410 · Cited by 100
MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy
Zhao, L., Li, J., Su, Y., Yang, L., Chen, L., Qiang, L., Wang, Y., Xiang, H., Tham, H. P., Peng, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz0575 · Cited by 100
Camel whey protein hydrolysates induced G2/M cellcycle arrest in human colorectal carcinoma
Murali, C., Mudgil, P., Gan, C., Tarazi, H., El‐Awady, R., Abdalla, Y., Amin, A., & Maqsood, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-86391-z · Cited by 100
Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
Aliabadi, F., Sohrabi, B., Mostafavi, E., Pazoki–Toroudi, H., & Webster, T. J. (2021) · Open Biology · doi:10.1098/rsob.200390 · Cited by 101
Radiation-induced senescence: therapeutic opportunities
Kim, J. H., Brown, S. L., & Gordon, M. N. (2023) · Radiation Oncology · doi:10.1186/s13014-022-02184-2 · Cited by 110
Nanoceria: an innovative strategy for cancer treatment
Tang, J., Moonshi, S. S., & Ta, H. T. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04694-y · Cited by 100
Skorokhod, O. A., Caione, L., Marrocco, T., Migliardi, G., Barrera, V., Arese, P., Piacibello, W., & Schwarzer, E. (2010) · Blood · doi:10.1182/blood-2010-03-272781 · Cited by 101
Curcumin and Emodin Down-Regulate TGF-β Signaling Pathway in Human Cervical Cancer Cells
Pooja, T., & Karunagaran, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120045 · Cited by 101
Mileo, A. M., Venere, D. D., Linsalata, V., Fraioli, R., & Miccadei, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.24029 · Cited by 99
Masgras, I., Carrera, S., de Verdier, P. J., Brennan, P., Majid, A., Makhtar, W. R. W., Tulchinsky, E. M., Jones, G. D. D., Roninson, I. B., & Macip, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250357 · Cited by 102
Kang, M. R., Yang, G., Place, R. F., Charissé, K., Epstein-Barash, H., Manoharan, M., & Li, L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1871 · Cited by 99
Deol, P., Evans, J. R., Dhahbi, J. M., Chellappa, K., Han, D. S. C., Spindler, S. R., & Sladek, F. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132672 · Cited by 103
Biasio, A. D., de Opakua, A. I., Mortuza, G. B., Molina, R., Cordeiro, T. N., Castillo, F., Villate, M., Merino, N., Delgado, S., Gil‐Carton, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7439 · Cited by 98
Rossi, M. S., Bucci, G., Rizzotto, D., Bordo, D., Marzi, M. J., Puppo, M., Flinois, A., Spadaro, D., Citi, S., Emionite, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09754-1 · Cited by 97
Jayaweera, S. P. E., Kanakanamge, S. P. W., Rajalingam, D., & Silva, G. N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740796 · Cited by 101
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100
Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
Wang, J., Hu, K., Guo, J., Cheng, F., Lv, J., Jiang, W., Lü, W., Liu, J., Pang, X., & Liu, M. (2016) · Nature Communications · doi:10.1038/ncomms11363 · Cited by 97
Dutta, A., Magnen, C. L., Mitrofanova, A., Ouyang, X., Califano, A., & Abate-Shen, C. T. (2016) · Science · doi:10.1126/science.aad9512 · Cited by 96
Self-citationDía, V. P., & Krishnan, H. B. (2016) · Scientific Reports · doi:10.1038/srep33532 · Cited by 95
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Weiß, A., Neubauer, M. C., Yerabolu, D., Kojonazarov, B. K., Schlueter, B. C., Neubert, L., Jonigk, D. D., Baal, N., Ruppert, C., Dorfmüller, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10135-x · Cited by 96
Wu, D., Liu, W.-S., Wang, J. C. K., Chen, C., Cheng, Y., & Lee, H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2316 · Cited by 95
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
He, M., Wang, Q.-Y., Yin, Q.-Q., Tang, J., Lu, Y., Zhou, C.-X., Duan, C.-W., Hong, D.-L., Tanaka, T. T., Chen, G.-Q., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.130 · Cited by 94
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells
Diep, C. H., Charles, N. J., Gilks, C. B., Kalloger, S. E., Argenta, P. A., & Lange, C. A. (2013) · Cell Cycle · doi:10.4161/cc.24550 · Cited by 96
Role of the translationally controlled tumor protein in DNA damage sensing and repair
Zhang, J., de Toledo, S. M., Pandey, B. N., Guo, G., Pain, D., Li, H., & Azzam, E. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106300109 · Cited by 97
Liu, Y., Kang, X., Niu, G., He, S., Zhang, T., Bai, Y., Li, Y., Hao, H., Chen, C., Shou, Z., et al. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1575229 · Cited by 93
Ma, C., Witkowski, M. T., Harris, J., Dolgalev, I., Sreeram, S., Qian, W., Tong, J., Chen, X., Aifantis, I., & Chen, W. (2020) · Science Advances · doi:10.1126/sciadv.aba5536 · Cited by 97
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
Wu, Z., Lee, S. T., Qiao, Y., Li, Z., Lee, P. L., Lee, Y. J., Jiang, X., Tan, J. Y., Aau, M., Lim, C. Z. H., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.48 · Cited by 95
Reeder, A., Attar, M. A., Nazario, L. A., Bathula, C. S., Zhang, A., Hochbaum, D., Roy, E., Cooper, K. L., Oesterreich, S., Davidson, N. E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.133 · Cited by 95
The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence
Gooding, A. J., Zhang, B., Jahanbani, F., Gilmore, H. L., Chang, J. C., Valadkhan, S., & Schiemann, W. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12716-6 · Cited by 93
Pro-Survival Role of MITF in Melanoma
Hartman, M. L., & Czyż, M. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.319 · Cited by 96
Kovačević, Ž., Sivagurunathan, S., Mangs, H., Chikhani, S., Zhang, D., & Richardson, D. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr046 · Cited by 91
Sabarwal, A., Agarwal, R., & Singh, R. P. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22512 · Cited by 93
Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity
Thiel, C. S., Paulsen, K., Bradacs, G., Lust, K., Tauber, S., Dumrese, C., Hilliger, A., Schoppmann, K., Biskup, J., Goelz, N., et al. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-1 · Cited by 91
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells
Wei, H.-J., Nickoloff, J. A., Chen, W.-H., Liu, H., Lo, W., Chang, Y.-T., Yang, P., Wu, C., Williams, D. F., Gelovani, J. G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2413 · Cited by 87
Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
Menéndez-Menéndez, J., & Martínez‐Campa, C. (2018) · International Journal of Endocrinology · doi:10.1155/2018/3271948 · Cited by 90
Crozier, L., Foy, R., Adib, R., Kar, A., Holt, J. A., Pareri, A. U., Valverde, J. M., Diazgranados, R. R., Weston, W. A., Wilson, R., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.016 · Cited by 108
Liao, Y.-J., Bai, H.-Y., Li, Z. H., Zou, J., Chen, J.-W., Zheng, F., Zhang, J. X., Mai, S.-J., Zeng, M.-S., Sun, H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.66 · Cited by 88
Choi, Y. H., & Yoo, Y. H. (2012) · Oncology Reports · doi:10.3892/or.2012.2060 · Cited by 89
Negishi, M., Wongpalee, S. P., Sarkar, S., Park, J.-H., Lee, K. Y., Shibata, Y., Reon, B. J., Abounader, R., Suzuki, Y., Sugano, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095216 · Cited by 89
Self-citationMicroRNA‐570 is a novel regulator of cellular senescence and inflammaging
Baker, J. R., Vuppusetty, C., Colley, T., Hassibi, S., Fenwick, P. S., Donnelly, L., Ito, K., & Barnes, P. J. (2018) · The FASEB Journal · doi:10.1096/fj.201800965r · Cited by 93
AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation
Ghodke, I., Remišová, M., Furst, A., Kilic, S., Reina‐San‐Martin, B., Poetsch, A. R., Altmeyer, M., & Soutoglou, E. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.010 · Cited by 93
Gupta, P., Rai, N., Verma, A. K., Saikia, D., Singh, S. P., Kumar, R., Singh, S. K., Kumar, D., & Gautam, V. (2022) · ACS Omega · doi:10.1021/acsomega.2c05605 · Cited by 88
Kim, S., Lee, J.-H., Kim, H. J., Park, M. K., Huh, J. W., Ro, J. Y., Oh, Y., Lee, S., & Lee, Y. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00288.2011 · Cited by 93
NFκB/p53 crosstalk—a promising new therapeutic target
Schneider, G., & Krämer, O. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.003 · Cited by 87
Love, I. M., Šekaric, P., Shi, D., Grossman, S. R., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.20864 · Cited by 89
Atkins, K. M., Thomas, L. L., González, J. B., Thomas, L., Auclair, S., Yin, J., Kang, H., Chung, J. H., Dikeakos, J. D., & Thomas, G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.049 · Cited by 86
Li, J., Huang, H., Li, Y., Li, L., Hou, W., & You, Z. (2016) · Oncology Reports · doi:10.3892/or.2016.5200 · Cited by 87
Oncogenic Role of PVT1 and Therapeutic Implications
Onagoruwa, O. T., Pal, G., Ochu, C., & Ogunwobi, O. O. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00017 · Cited by 87
The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective
Xiao, Y., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13246214 · Cited by 84
Proliferating Cell Nuclear Antigen Structure and Interactions
Biasio, A. D., & Blanco, F. J. (2013) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-411637-5.00001-9 · Cited by 87
Deciphering the role of Nuclear Factor-κB in cellular senescence
Vaughan, S., & Jat, P. (2011) · Aging · doi:10.18632/aging.100390 · Cited by 90
Jiang, R., & Lönnerdal, B. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0094 · Cited by 89
Gordon, E. M., Ravicz, J. R., Liu, S., Chawla, S. P., & Hall, F. L. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1657 · Cited by 87
Regulation of the p53 transcriptional response by structurally diverse core promoters
Morachis, J. M., Murawsky, C. M., & Emerson, B. M. (2010) · Genes & Development · doi:10.1101/gad.1856710 · Cited by 86
Li, Q., Kawamura, K., Ma, G., Iwata, F., Numasaki, M., Suzuki, N., Shimada, H., & Tagawa, M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.002 · Cited by 86
Ripening-induced chemical modifications of papaya pectin inhibit cancer cell proliferation
do Prado, S. B. R., Ferreira, G. F., Harazono, Y., Shiga, T. M., Raz, A., Carpita, N. C., & Fabi, J. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-16709-3 · Cited by 86
CEP55 contributes to human gastric carcinoma by regulating cell proliferation
Tao, J., Zhi, X., Tian, Y. Y., Li, Z., Zhu, Y., Wang, W., Xie, K.-L., Tang, J., Zhang, X., Wang, L., et al. (2014) · Tumor Biology · doi:10.1007/s13277-013-1578-1 · Cited by 85
Pierozan, P., & Karlsson, O. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2077-8 · Cited by 87
Schmidt, K., Carroll, J. S., Yee, E., Thomas, D. D., Wert-Lamas, L., Neier, S. C., Sheynkman, G., Ritz, J., & Novina, C. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.101 · Cited by 85
HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice
Zhang, Y., Yang, Y., Yang, F., Liu, X., Zhan, P., Wu, J., Wang, X., Wang, Z., Tang, W., Sun, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38771-4 · Cited by 85
Michaeloudes, C., Chang, P., Petrou, M., & Chung, K. F. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1780oc · Cited by 85
New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
Jelinic, P., & Levine, D. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0906-t · Cited by 85
Local, A., Zhang, H., Benbatoul, K. D., Folger, P., Sheng, X., Tsai, C., Howell, S. B., & Rice, W. G. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1209 · Cited by 85
On the role of cystatin C in cancer progression
Leto, G., Crescimanno, M., & Flandina, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.013 · Cited by 84
Banerjee, D., Langberg, K. A., Abbas, S., Odermatt, E., Yerramothu, P., Volaric, M. P., Reidenbach, M. A., Krentz, K. J., Rubinstein, C. D., Brautigan, D. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26240-9 · Cited by 88
Self-citationCell cycle dysregulation in cancer
Glaviano, A., Singh, S. K., Lee, E. H. C., Okina, E., Lam, H. Y., Carbone, D., Reddy, E. P., O’Connor, M. J., Koff, A., Singh, G., et al. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100030 · Cited by 98
The Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective
Bezine, E., Vignard, J., & Mirey, G. (2014) · Cells · doi:10.3390/cells3020592 · Cited by 92
SOX2 Modulates Reprogramming of Gene Expression in Two-Cell Mouse Embryos1
Pan, H., & Schultz, R. M. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.090886 · Cited by 83
Hou, Z., Guo, K., Sun, X., Hu, F., Chen, Q., Luo, X., Wang, G., Hu, J., & Sun, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0922-x · Cited by 82
Pierozan, P., Cattani, D., & Karlsson, O. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02848-6 · Cited by 87
Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants
Bressan, R. B., Southgate, B., Ferguson, K. M., Blin, C., Grant, V., Alfazema, N., Wills, J. C., Marqués‐Torrejón, M. Á., Morrison, G. M., Ashmore, J., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.016 · Cited by 88
Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
Hong, S., Yoon, S., Moelling, C., Arthan, D., & Park, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012591 · Cited by 83
Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells
Elbaz, H. A., Stueckle, T. A., Wang, H.-Y. L., O'Doherty, G. A., Lowry, D. T., Sargent, L. M., Wang, L., Dinu, C. Z., & Rojanasakul, Y. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.007 · Cited by 84
Moulder, D. E., Hatoum, D., Tay, E. S. E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 87
Vijayaraghavalu, S., Dermawan, J. K. T. K., Cheriyath, V., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3004622 · Cited by 86
Mechanism of metastasis suppression by luteolin in breast cancer
Cook, M. T. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s144202 · Cited by 82
Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression
Kang, Z., Wang, C., Zhang, W., Zhang, J., Yuan, C., Zhao, P., Lin, Y., Hong, S., Li, C., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098894 · Cited by 82
PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
Hoefer, J., Schäfer, G., Klocker, H., Erb, H. H. H., Mills, I. G., Hengst, L., Puhr, M., & Čulig, Z. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.026 · Cited by 82
Zhi, X., Zhao, D. H., Wang, Z., Zhou, Z., Wang, C., Chen, W., Liu, R., & Chen, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0562 · Cited by 85
POU2F2-oriented network promotes human gastric cancer metastasis
Wang, S.-M., Tie, J., Wang, W., Hu, S.-J., Yin, J., Yi, X.-F., Tian, Z., Zhang, X.-Y., Li, M., Li, Z., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308932 · Cited by 81
Tiffen, J. C., Gunatilake, D., Gallagher, S. J., Gowrishankar, K., Heinemann, A., Cullinane, C. M., Dutton‐Regester, K., Pupo, G. M., Strbenac, D., Yang, J. Y. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4809 · Cited by 81
Mukherjee, A. K., Sharma, S., Sengupta, S., Saha, D., Kumar, P., Hussain, T., Srivastava, V. K., Roy, S. D., Shay, J. W., & Chowdhury, S. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007782 · Cited by 77
Barakat, A., Islam, M. S., Ghawas, H. M., Al‐Majid, A. M., El‐Senduny, F. F., Badria, F. A.-E., Elshaier, Y. A. M. M., & Ghabbour, H. A. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.053 · Cited by 81
Zhang, X., Liu, Z., Xu, B., Sun, Z.-L., Gong, Y., & Shao, C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.035 · Cited by 81
Russo, A., Esposito, D., Catillo, M., Pietropaolo, C., Crescenzi, E., & Russo, G. (2012) · Cell Cycle · doi:10.4161/cc.22963 · Cited by 81
HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes
Lepiller, Q., Abbas, W., Kumar, A., Tripathy, M. K., & Herbein, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059591 · Cited by 86
Ma, Y., Liang, A., Fan, Y., Huang, Y., Zhao, X., Sun, Y. W., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8715 · Cited by 81
Targeted inactivation of murineDdx3x: essential roles ofDdx3xin placentation and embryogenesis
Chen, C.-Y., Chan, C.-H., Chen, C., Tsai, Y.-S., Tsai, T.-Y., Lee, Y. W., & You, L. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw143 · Cited by 79
Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies
Ebert, S. M., Al-Zougbi, A., Bodine, S. C., & Adams, C. M. (2019) · Physiology · doi:10.1152/physiol.00003.2019 · Cited by 80
Kumar, R., Dwivedi, P. D., Dhawan, A., Das, M., & Ansari, K. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr143 · Cited by 80
Faheem, M. M., Seligson, N. D., Ahmad, S. M., Rasool, R. U., Gandhi, S. G., Bhagat, M., & Goswami, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0286-z · Cited by 84
Mühleder, S., Fernández-Chacón, M., García-Gónzalez, I., & Benedito, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03664-y · Cited by 84
Metadata
- Authors
- Abbas, T., & Dutta, A.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Abbas, Tarek
- Dutta, Anindya
- Venue
- Nature Reviews Cancer
- Published
- 2009-05-14
- Volume
- 9
- Issue
- 6
- Pages
- 400-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2722839
- OpenAlex
- W2162262059
- Cited by
- 2,712
- References
- 236
- Citations by year
- 2026: 99 · 2025: 156 · 2024: 161 · 2023: 206 · 2022: 182 · 2021: 205 · 2020: 204 · 2019: 180 · 2018: 191 · 2017: 196 · 2016: 148 · 2015: 160 · 2014: 142 · 2013: 151 · 2012: 122
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA089406, R01 CA 89406, T32CA009109)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p21, cyclin-dependent kinase inhibitors, cell cycle arrest, therapeutic target, cell transformation
- MeSH terms
- Animals, Cell Cycle, Humans, Neoplasms, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
